Class II recall: American Regent, Inc.: Nitroglycerin injection, USP, 50 mg/10 mL (5 mg/mL), packaged in a) 10 mL vials

The FDA reports a Class II recall of American Regent's nitroglycerin injection, USP, 50 mg/10 mL (5 mg/mL), distributed in 10 mL vials (NDC 0517-4810-01) and 25x10mL vial packs (NDC 0517-4810-25). The recall was initiated due to the presence of particulate matter in the product, identified as hair, glass, and/or paraformaldehyde, according to the FDA notice.

Most relevant for: patients receiving nitroglycerin injection for acute cardiovascular conditions who may have received the affected product batches

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.